1.	Phase III Chemotherapy with IPP, IPP/ADR and CIA (IPP/ADR/CCNU) for Extensive non-Oat Cell Lung Carcinoma (Summary last modified 06/97) Phase: Phase III Type: Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: SWOG-7701
2.	Phase III Vitamin C vs Placebo in Patients with Advanced Colorectal Cancer Who Have Had No Prior Immunosuppressive Therapy Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MAYO-790602
3.	Study of the Effect of Nutritional Intervention on Esophageal Cancer in Linxian, People's Republic of China (Summary Last Modified 10/88) Phase: Phase III Type: Prevention Status: Completed Age: 40 to 69 Sponsor: Protocol IDs: DCPC-CPSB-11204
4.	Phase III Randomized, Double-Blind Study of Multiple Vitamins at the Recommended Daily Allowance (RDA) vs Multiple Vitamins at the RDA plus High-Dose Vitamins A, B6, C, and E in Patients with Transitional Cell Carcinoma of the Bladder (Summary Last Modified 06/91) Phase: Phase III Type: Supportive care Status: Closed Age: any age Sponsor: Protocol IDs: WVU-11715, NCI-V91-0025
5.	Phase I/II Study of Arsenic Trioxide Plus Ascorbic Acid in Patients With Recurrent or Refractory Multiple Myeloma. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase II, Phase I Type: Treatment Status: Completed Age: Over 18 Sponsor: NCI Protocol IDs: SCCC-20010, SCCC-NCI-43, NCI-43, NCT00006021, 43
6.	Phase I/II Study of High-Dose Ascorbic Acid Potentiation of Alkylating Agents in Children with Advanced Cancer in Relapse Phase: Phase II, Phase I Type: Treatment Status: Closed Age: under 18 Sponsor: Protocol IDs: MDA-P-7901n
7.	Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 75 and under Sponsor: Other Protocol IDs: 2005-0893, NCT00469209
8.	Phase II Ifosfamide Chemotherapy for Resistant Disseminated Malignant Melanoma Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: SWOG-7813
9.	Phase II Induction and Maintenance Combination Chemotherapy with IHOP (ADR/IPP/PRED/VCR) for Acute Lymphocytic Leukemia in Relapse Phase: Phase II Type: Treatment Status: Closed Age: under 75 Sponsor: NCI Protocol IDs: SWOG-7842
10.	Phase II Induction with High-Dose Prednisone plus VCR/MTX Followed by Aggressive Consolidation Chemotherapy for Refractory non-Hodgkin's Lymphoma Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: NCI-D81-035-695, OSU-IOU-8107
11.	Phase II Trials of 13 Additional Chemotherapeutic Agents, Alone or Combined for non-Small Cell Lung Cancer Phase: Phase II Type: Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: EST-2575-II
12.	Phase II Study of Arsenic Trioxide, Ascorbic Acid, and Dexamethasone in Patients With Relapsed or Refractory Stage II or III Multiple Myeloma Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: MWCRG-CTI-T12017, MWCRG-03-82, MWCRG-WIRB-20040041
13.	Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder Phase: Phase II Type: Treatment Status: Completed Age: Over 18 Sponsor: NCI, Other Protocol IDs: CASE4Y04, P30CA043703, CCF-7671, CASE-CCF-7671, NCT00274820
14.	Safety of Antioxidants During GYN Cancer Care Phase: Phase II Type: Treatment Status: Closed Age: No age specified Sponsor: Other Protocol IDs: 10006, NCT00284427
15.	Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: CDR0000479708, ONCOTHER-20052183, ONCOTHER-BAM2005, MILLENNIUM-ONCOTHER-20052183, NCT00317811
16.	L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes Phase: Phase II Type: Treatment Status: Temporarily closed Age: No age specified Sponsor: Other Protocol IDs: SMCIRB-98-04-02, NCT00329498
17.	Cephalon Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndrome Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: Pro00011792, 7667A, NCT00621023
18.	Pilot Trial of Intravenous Vitamin C in Refractory Non-Hodgkin Lymphoma (NHL) Phase: Phase II Type: Treatment Status: Completed Age: Over 18 Sponsor: Other Protocol IDs: IND-77486, NCT00626444
19.	Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease Phase: Phase II Type: Supportive care, Treatment Status: Temporarily closed Age: 18 and over Sponsor: Other Protocol IDs: L500HD, NCT01125449
20.	Phase I Randomized Study of Selenium With or Without Vitamin E for the Prevention of Lung Cancer in Smokers (Summary Last Modified 11/2000) Phase: Phase I Type: Prevention Status: Closed Age: 18 to 70 Sponsor: NCI Protocol IDs: KUMC-7159-97, NCI-P00-0152
21.	Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000445464, P30CA022453, WSU-D-2869, WSU-HIC-01705M1F, NCT00258245
22.	Study of High-Dose Intravenous (IV) Vitamin C Treatment in Patients With Solid Tumors Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: CTCA 06-04, Ascorbic Acid Injection, NCT00441207
23.	Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid Leukemia Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: 07-0916 / 201011797, NCT00671697
24.	Intravenous Vitamin C in Combination With Standard Chemotherapy for Pancreatic Cancer Phase: Phase I Type: Treatment Status: Completed Age: 18 to 75 Sponsor: Other Protocol IDs: IND77486, NCT00954525
25.	A Research Trial of High Dose Vitamin C and Chemotherapy for Metastatic Pancreatic Cancer Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: 200804753, NCT01049880